HomeO15 โข FRA
add
Insilico Medicine Cayman TopCo
Nakaraang pagsara
โฌ7.25
Sakop ng araw
โฌ7.95 - โฌ8.05
Sakop ng taon
โฌ5.35 - โฌ9.00
Market cap
43.07B HKD
Average na Volume
855.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 14.39M | 10.09% |
Gastos sa pagpapatakbo | 30.23M | -1.90% |
Net na kita | -166.55M | -1,225.72% |
Net profit margin | -1.16K | -1,104.25% |
Kita sa bawat share | โ | โ |
EBITDA | -17.70M | 5.63% |
Aktuwal na % ng binabayarang buwis | -0.01% | โ |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 447.27M | 255.14% |
Kabuuang asset | 489.98M | 240.26% |
Kabuuang sagutin | 37.96M | -95.30% |
Kabuuang equity | 452.03M | โ |
Natitirang share | 557.42M | โ |
Presyo para makapag-book | 8.95 | โ |
Return on assets | -9.60% | โ |
Return on capital | -10.27% | โ |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -166.55M | -1,225.72% |
Cash mula sa mga operasyon | โ | โ |
Cash mula sa pag-invest | โ | โ |
Cash mula sa financing | โ | โ |
Net change in cash | โ | โ |
Malayang cash flow | โ | โ |
Tungkol
Insilico Medicine is a biotechnology company headquartered in Boston, Massachusetts, with additional facilities in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery. Wikipedia
Itinatag
2014
Website
Mga Empleyado
317
